LP-062 Two-year outcomes by belimumab additive on standard of care in patients with systemic lupus erythematosus: a single center retrospective cohort study
Main Authors: | Yu Matsueda, Yoshiyuki Arinuma, Yasuhiro Hasegawa, Kenji Oku, Kunihiro Yamaoka, Tomoki Tanaka, Tatsuhiko Wada, Hirotomo Asakura |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-07-01
|
Series: | Lupus Science and Medicine |
Similar Items
-
LSO-097 Captopril preventing blood brain barrier breach by anti-smith antibody
by: Yoshiyuki Arinuma, et al.
Published: (2023-07-01) -
LP-189 Effect of belimumab in patients with systemic lupus erythematosus treated with minimal or no steroid
by: Ji Seon Oh, et al.
Published: (2023-07-01) -
Involvement of the complement system in immune thrombocytopenia: review of the literature
by: Risa Shindo, et al.
Published: (2023-10-01) -
Belimumab for systemic lupus erythematosus – Focus on lupus nephritis
by: Marlene Plüß, et al.
Published: (2022-11-01) -
LP-191 Baseline profile of systemic lupus erythematosus patients on treatment with belimumab of a Spanish multicenter cohort
by: Íñigo Rúa-Figueroa, et al.
Published: (2023-07-01)